This is a Phase 4, observational, open study in patients whom their doctor for clinical practice prescribes levamlodipine. No medication was provided by the sponsor. The planned observation time is 8 weeks. The 8 weeks of observation involves an evaluation of baseline followed by information gathered from the assessment visits at week 4 and week 8, or clinical practice.
Study Type
OBSERVATIONAL
Enrollment
2,000
Country Club Bogota
Bogotá, Colombia
RECRUITINGEffect of therapy in the management of hypertension and other cardiovascular diseases
The change from Baseline in Blood Pressure at 8 weeks will be measure to evaluate th efficacy of the therapy.
Time frame: 8 weeks
Number of Participants with Adverse Events as a Measure of Safety and Tolerability
The number of Participants with Serious and Non- seriuous Adverse Events wil be mesure to evaluate the tolerability and safety profile in 8 weeks follow up.
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.